Introduction
The dualistic paradigm
Ovarian surface epithelium and tubal epithelium as possible tumour origins
Serous carcinomas of the ovary, tube and peritoneum
Ovarian cancer cell lines need better characterization
Commercially available ovarian cancer cell lines
ID | Name | Homepage |
---|---|---|
ATCC | American Type Culture Collection | |
ECACC | European Collection of Cell Cultures, a part of the Health Protection Agency | |
DSMZ | German Collection of Microorganisms and Cell Cultures | |
JCRB | Japanese Collection of Research Bioresources | |
CellBank Australia | Australian cell bank – Cell Bank Australia | |
NCBI | National Cell Bank of Iran |
ID number | Cell line | Origin | Source |
---|---|---|---|
Homo sapiens– human | |||
1 | 222 | ||
2 | 2008 | Ovary | |
3 | 2008/C13.R | Ovarian adenocarcinoma | NCBI |
4 | 41Ma/OAW28 | Ovarian cancer ascites | ECACC |
5 | 41 M cisR | Ovarian cancer ascites | |
6 | 59 M | Ovarian cancer ascites | ECACC |
7 | A2780 | Ovarian adenocarcinoma | ECACC |
8 | A2780ADR | Ovarian adenocarcinoma; A2780 | ECACC |
9 | A2780cis | Ovarian adenocarcinoma; A2780 | ECACC |
10 | A2780 CP | Ovarian adenocarcinoma | NCBI |
11 | A2780 S | Ovarian adenocarcinoma | NCBI |
12 | Caov-3 | Ovarian adenocarcinoma | ATCC |
13 | Caov-4 | Metastatic fallopian tube mass from ovarian tumour | ATCC/NCBI |
14 | CH1 | Ovarian adenocarcinoma | |
15 | CH1cisR | Ovarian adenocarcinoma | |
16 | COLO-704 | Metastatic colonic ascites from ovarian tumour | DSMZ |
17 | COV318 | Ovarian cancer ascites | ECACC |
18 | COV362 | Ovarian cancer pleural effusion | ECACC |
19 | COV362.4 | Ovarian cancer pleural effusion; COV362 | ECACC |
20 | COV413A | Metastatic sigmoid mass from ovarian tumour | ECACC |
21 | COV413B | Metastatic bladder dome mass from ovarian tumour | ECACC |
22 | COV434 | Ovarian granulosa tumour from a solid primary tumour | ECACC |
23 | COV504 | Ovarian pleural effusion | ECACC |
24 | COV644 | Ovarian cancer (primary tumor) | ECACC |
25 | EFO-21 | Ovarian cancer ascites | DSMZ |
26 | EFO27 | Metastatic omental mass from ovarian tumour | DSMZ |
27 | ES-2 | Ovarian adenocarcinoma | ATCC |
28 | FU-OV-1 | Malignant ovarian mass | DSMZ |
29 | HAC-2 | Ovarian cancer cell derived from mesonephros | JCRB |
30 | Hey-A8 | Ovary | CCLE |
31 | HOSE 6-3 | Ovarian surface epithelium | |
32 | HOSE 17-1 | Ovarian surface epithelium | |
33 | HOSE 105 | Ovarian surface epithelium | |
34 | HOSE 111 | Ovarian surface epithelium | |
35 | HOSE 129 | Ovarian surface epithelium | |
36 | HOSE 130 | Ovarian surface epithelium | |
37 | Hs 38.T | Ovarian teratoma | ATCC |
38 | Hs 571.T | Ovarian adenocarcinoma | ATCC |
39 | Hs904.T | ||
40 | IGROV1 | Ovarian adenocarcinoma | |
41 | JHOC-5 | Ovarian adenocarcinoma | CCLE |
42 | JHOM-1 | Ovarian adenocarcinoma | CCLE |
43 | JHOM-2B | Ovarian adenocarcinoma | CCLE |
44 | JHOS-2 | Ovarian adenocarcinoma | CCLE |
45 | JHOS-4 | Ovarian adenocarcinoma | CCLE |
46 | KURAMOCHI | Ovarian cancer ascites | JCRB |
47 | MCAS | Ovarian adenocarcinoma | JCRB |
48 | NCC-OvC-K119 | Ovarian adenocarcinoma | JCRB |
49 | OAW28/41 M | Ovarian cancer ascites | ECACC |
50 | OAW42 | Ovarian cancer ascites | ECACC |
51 | OC 314 | Ovarian cancer ascites | CCLE |
52 | OC 315 | Ovarian adenocarcinoma | CCLE |
53 | OC 316 | Ovarian cancer ascites | CCLE |
54 | ONCO-DG-1a | Ovarian adenocarcinoma | DSMZ |
55 | OV-7 | Ovarian adenocarcinoma derived from solid tumour | ECACC |
56 | OV17R | Ovarian cancer ascites | ECACC |
57 | OV56 | Ovarian cancer ascites | ECACC |
58 | OV-58 | Ovarian cancer ascites | ECACC |
59 | OV-90 | Ovarian cancer ascites | ATCC |
60 | OV-1063a | ||
61 | OVC1-PI 32 | Ovary | NCBI |
62 | OVCAR-3 | Ovarian cancer ascites | ATCC/NCBI |
63 | OVCAR-4 | Ovarian adenocarcinoma | CCLE |
64 | OVCAR-8 | Ovarian adenocarcinoma | CCLE |
65 | OVISE | Metastatic ovarian adenocarcinoma | JCRB/CCLE |
66 | OVK18 | Ovarian adenocarcinoma | CCLE |
67 | OVKATE | Ovarian adenocarcinoma | JCRB |
68 | OVMANA | Ovarian adenocarcinoma | JCRB |
69 | OVMIUa | Ovarian adenocarcinoma | JCRB |
70 | OVMIU-IIa | Ovarian adenocarcinoma | JCRB |
71 | OVSAHO | Ovarian adenocarcinoma | JCRB |
72 | OVSAYOa | Ovarian adenocarcinoma | JCRB |
73 | OVTOKO | Ovarian adenocarcinoma | JCRB |
74 | PA-1 | Ovarian cancer ascites | ATCC/JCRB/ECACC |
75 | PA-1/6TG-r | Ovarian cancer ascites | JCRB |
76 | PEA1 | Ovarian cancer pleural effusion | ECACC |
77 | PEA2 | Ovarian cancer ascites | ECACC |
78 | PEO1 | Ovarian cancer ascites | ECACC |
79 | PEO4 | Ovarian cancer pleural effusion | ECACC |
80 | PEO6 | Ovarian cancer ascites | ECACC |
81 | PEO14b | Ovarian cancer ascites | ECACC |
82 | PEO16 | Ovarian cancer ascites | ECACC |
83 | PEO23b | Ovarian cancer ascites | ECACC |
84 | RKN | Ovarian adenocarcinoma | JCRB |
85 | RMG-Ia | Ovarian adenocarcinoma | JCRB |
86 | RMG-II | Ovarian adenocarcinoma | JCRB |
87 | RMUG-La | Ovarian adenocarcinoma | JCRB |
88 | RMUG-S | Ovarian adenocarcinoma | JCRB |
89 | RTSGc | Ovarian adenocarcinoma | JCRB |
90 | SCC60 | ||
91 | SK-OV-3 | Ovarian cancer ascites | ATCC/NCBI/ECACC |
92 | SNU-8 | Ovarian adenocarcinoma | CCLE |
93 | SNU-119 | Ovarian adenocarcinoma | CCLE |
94 | SNU-840 | Ovarian adenocarcinoma | CCLE |
95 | SW 626 | Ovarian metastatic mass from colon tumour | ATCC/ECACC |
96 | TE 84.T | Ovarian adenocarcinoma | ATCC |
97 | TO14b | Metastatic omental mass from ovarian tumour | ECACC |
98 | TOV-21G | Malignant ovarian mass | ATCC |
99 | TOV-81D | Malignant ovarian mass | |
100 | TOV-112D | Malignant ovarian mass | ATCC |
101 | TYK-nu | Ovarian adenocarcinoma | JCRB |
102 | TYK-nu.CP-r | Ovarian adenocarcinoma | JCRB |
103 | UC1-101 | Ovarian adenocarcinoma | |
104 | UC1-107 |
Cricetulus griseus– Chinese hamster | |||
---|---|---|---|
105 | A2 | Ovary | ECACC |
106 | A2H | Ovary; A2 | ECACC |
107 | AR-EcoScreen | Ovary | JCRB |
108 | CHO | Ovary | ECACC/NCBI |
109 | CHO 1–15 500 | Ovary | NCBI |
110 | CHO CD28 | Ovary | NCBI |
111 | CHO-CHRM1 | Ovary; CHO-K1 | ECACC |
112 | CHO-CHRM2 | Ovary; CHO-K1 | ECACC |
113 | CHO-CHRM5 | Ovary; CHO-K1 | ECACC |
114 | CHO DG-44 | Ovary | NCBI |
115 | CHO/dhFr- | Ovary | ECACC/DSMZ/NCBI |
116 | CHO/dhFr- Ac-free | Ovary; CHO/dhFr- | ECACC |
117 | CHO-FFAR2 | Ovary; CHO-K1 | ECACC |
118 | CHO-GPR120 | Ovary; CHO-K1 | ECACC |
119 | CHO/HGPRT | Ovary | JCRB |
120 | CHO (His9) | Ovary | JCRB |
121 | CHO-K1 | Ovary; CHO | ECACC/JCRB/DSMZ |
122 | CHO-K1/SF | Ovary; CHO-K1 | ECACC |
123 | CHO-OPRL1 | Ovary; CHO-K1 | ECACC |
124 | CHO (pMAM-HSluc) | Ovary | JCRB |
125 | CHO (pMAM-luc) | Ovary | JCRB |
126 | CHO Protein-Free | Ovary; CHO | ECACC |
127 | CHO-SSTR1 | Ovary; CHO-K1 | ECACC |
128 | GRL101 (KC7) | Ovary | ECACC |
129 | GRL101 (MIX) | Ovary | ECACC |
130 | M1WT3 | Ovary; CHO-K1 | ECACC |
131 | NCTC 4206 | Peritoneum; B14FAF28-G3 | ECACC |
132 | P22 | Ovary | ECACC |
133 | RR-CHOKI | Ovary; CHO-K1 | ECACC |
134 | T02J-7/10 (CHO-M3 (CHRM3)) | Ovary; CHO-K1 | ECACC |
135 | T02J-9/10 (CHO-H2 (HRH2)) | Ovary; CHO-K1 | ECACC |
136 | T02J-10/10 (CHO-GCGR (GCGR)) | Ovary; CHO-K1 | ECACC |
137 | T26J-1/09 (CHO-Beta-2 (ADRB2)) | Ovary; CHO-K1 | ECACC |
138 | T35J-5/09 (CHO-FFAR3 (FFAR3)) | Ovary; CHO-K1 | ECACC |
139 | UT-1 | Ovary; CHO-K1 | ECACC |
140 | XrS6 | Ovary; CHO-K1 | ECACC |
141 | Xrs6-hamKu80 | Ovary; CHO-K1 | ECACC |
Mus musculus
– mouse
| |||
142 | OV3121 | Ovary | JCRB |
143 | OV3121-ras4 | Ovary | JCRB |
144 | OV3121-ras7 | Ovary | JCRB |
145 | p53-def-MOSE | Ovary | JCRB |
146 | T-Ag-MOSE | Ovary | JCRB |
Sus domesticus
– Pig
| |||
147 | AVG-16 | Ovary follicle | ECACC |
Spodoptera frugiperda
– fall army worm
| |||
148 | Sf 9 | Pupal ovary | NCBI/ECACC |
149 | Sf 9 TitreHigh AC free | Pupal ovary; Sf 9 CL | ECACC |
150 | Sf 21 | Pupal ovary | NCBI/ECACC |
151 | Sf 21 TitreHigh AC free | Pupal ovary; Sf 21 CL | ECACC |
Esox lucius
– Northern pike fish
| |||
152 | PG | Ovary | ECACC |
Ictalurus punctatus
– channel catfish
| |||
153 | CCO | Ovary | ECACC |
The role of genetic changes in the characterization of ovarian cancer cell lines
Origin specified (cell line banks) | |||||
---|---|---|---|---|---|
Ascites | Metastasis | Ovary | Pleural effusion | ||
Origin specified (original references)
|
Ascites
| 9 | 0 | 5 | 0 |
Metastasis
| 0 | 2 | 6 | 0 | |
Not specified
| 0 | 0 | 11 | 0 | |
Ovary
| 0 | 0 | 9 | 0 | |
Pleural effusion
| 0 | 0 | 0 | 1 |
Origin specified (cell line banks) | ||||||||
---|---|---|---|---|---|---|---|---|
Clear cell | Endometrioid | Mixed | Mucinous | Other | Serous | Unknown | ||
Origin specified (original references)
|
Clear cell
| 6 | 0 | 0 | 0 | 0 | 0 | 0 |
Endometrioid
| 0 | 2 | 0 | 0 | 0 | 0 | 0 | |
Mixed
| 0 | 0 | 1 | 0 | 0 | 0 | 1 | |
Mucinous
| 0 | 0 | 0 | 3 | 2 | 0 | 0 | |
Other
| 0 | 0 | 0 | 0 | 3 | 0 | 0 | |
Serous
| 0 | 0 | 0 | 1 | 6 | 7 | 1 | |
Unknown
| 0 | 0 | 0 | 0 | 7 | 0 | 1 |